Quick Answer
Arcadia Biosciences, Inc. reported Total Assets of $6.55 million for fiscal year 2025.
Arcadia Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $6.55M | -51.6% |
| 2024 | $13.52M | -31.4% |
| 2023 | $19.70M | -31.9% |
| 2022 | $28.92M | -34.1% |
| 2021 | $43.92M | -7.2% |
| 2020 | $47.35M | +45.4% |
| 2019 | $32.57M | +35.6% |
| 2018 | $24.02M | +45.0% |
| 2017 | $16.57M | -70.7% |
| 2016 | $56.57M | -23.8% |
| 2015 | $74.24M | +198.3% |
| 2014 | $24.89M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.58M | -43.7% | +10.2% |
| June 30, 2025 | $7.79M | -55.2% | -40.0% |
| March 31, 2025 | $12.99M | -19.0% | -3.9% |
| December 31, 2024 | $13.52M | -31.4% | -11.3% |
| September 30, 2024 | $15.24M | -35.1% | -12.3% |
| June 30, 2024 | $17.37M | -35.2% | +8.2% |
| March 31, 2024 | $16.05M | -47.2% | -18.6% |
| December 31, 2023 | $19.70M | -31.9% | -16.0% |
- Arcadia Biosciences, Inc. showed a decrease of -51.6% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, Arcadia Biosciences, Inc.’s total assets has declined by 73.7% (from $24.89 million to $6.55 million).
- The most recent figure is from Arcadia Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: